Identification of optimum computational protocols for modeling the aryl hydrocarbon receptor (AHR) and its interaction with ligands

被引:20
|
作者
Jogalekar, Ashutosh S. [1 ]
Reiling, Stephan [1 ]
Vaz, Roy J. [1 ]
机构
[1] Sanofi Aventis US, Struct, Design, Informat, Bridgewater, NJ 08807 USA
关键词
Aryl hydrocarbon receptor (AHR); Docking; Scoring; Molecular dynamics; MM-GBSA; CYP1A1; TCDD; BINDING DOMAIN; ACTIVATION; DOCKING; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; DIBENZOFURANS; INDUCTION; COMPLEXES; RESIDUES; DIOXINS; CYP1A1;
D O I
10.1016/j.bmcl.2010.09.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aryl hydrocarbon receptor (AHR) is one of the principal xenobiotic receptors in living organisms and is responsible for interacting with several drugs and environmental toxins, most notably tetrachlorodibenzodioxin (TCDD). Binding of diverse agonists to AHR initiates an extensive set of downstream gene expression responses and thus identifies AHR among a key set of proteins responsible for mediating interactions between living organisms and foreign molecules. While extensive biochemical investigations on the interaction of AHR with ligands have been carried out, studies comparing the abilities of specific computational algorithms in explaining the potency of known AHR ligands are lacking. In this study we use molecular dynamics simulations to identify a physically realistic conformation of the AHR that is relevant to ligand binding. We then use two sets of existing data on known AHR ligands to evaluate the performance of several docking and scoring protocols in rationalizing the potencies of these ligands. The results identify an optimum set of protocols that could prove useful in future AHR ligand discovery and design as a target or anti-target. Exploration of the details of these protocols sheds light on factors operating in modeling AHR ligand binding. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6616 / 6619
页数:4
相关论文
共 50 条
  • [1] Molecular modeling of the aryl hydrocarbon receptor and its interaction with ligands
    Jogalekar, Ashutosh S.
    Reiling, Stephan
    Vaz, Roy J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [2] The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer
    Safe, Stephen
    Zhang, Lei
    CANCERS, 2022, 14 (22)
  • [3] Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
    Safe, Stephen
    Jin, Un-ho
    Park, Hyejin
    Chapkin, Robert S.
    Jayaraman, Arul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 16
  • [4] Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands
    Bisson, William H.
    Koch, Daniel C.
    O'Donnell, Edmond F.
    Khalil, Sammy M.
    Kerkvliet, Nancy I.
    Tanguay, Robert L.
    Abagyan, Ruben
    Kolluri, Siva Kumar
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (18) : 5635 - 5641
  • [5] Ligands and agonists of the aryl hydrocarbon receptor AhR: Facts and myths
    Sladekova, Lucia
    Mani, Sridhar
    Dvorak, Zdenek
    BIOCHEMICAL PHARMACOLOGY, 2023, 213
  • [6] Predictive modeling of aryl hydrocarbon receptor (AhR) agonism
    Goya-Jorge, Elizabeth
    Giner, Rosa M.
    Veitia, Maite Sylla-Iyarreta
    Gozalbes, Rafael
    Barigye, Stephen J.
    CHEMOSPHERE, 2020, 256 (256)
  • [7] Identification of new endogenous ligand of receptor AhR (Aryl hydrocarbon Receptor)
    Bessede, A.
    Lagroye, I
    Geffard, M.
    Veyret, B.
    BULLETIN DU CANCER, 2009, 96 : S24 - S24
  • [8] Aryl hydrocarbon receptor (AhR) biology
    Bell, DR
    TOXICOLOGY, 2004, 194 (03) : 219 - 220
  • [9] Immunoregulation by the Aryl Hydrocarbon Receptor (AHR).
    Kerkvliet, N. I.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2010, 5 : S14 - S14
  • [10] The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin
    Dawe, Hannah R.
    Di Meglio, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)